SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-18-000420
Filing Date
2018-07-25
Accepted
2018-07-25 12:29:13
Documents
1
Group Members
CLARUS VENTURES II GP, L.P.CLARUS VENTURES II, LLCDENNIS HENNERFINNY KURUVILLAKURT WHEELERNICHOLAS GALAKATOSNICHOLAS SIMONROBERT LIPTAK

Document Format Files

Seq Description Document Type Size
1 CLARUS LIFESCIENCES II, L.P. NANOSTRING TECHNOLOGIES, INC. -- SCHEDULE 13D clarus2-nanostring13d_18221.htm SC 13D/A 275290
  Complete submission text file 0001072613-18-000420.txt   277067
Mailing Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109
Business Address 530 FAIRVIEW AVENUE NORTH SEATTLE WA 98109 206-378-6266
NanoString Technologies Inc (Subject) CIK: 0001401708 (see all company filings)

IRS No.: 200094687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87534 | Film No.: 18968239
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
Business Address 101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142 617-949-2200
Clarus Lifesciences II, L.P. (Filed by) CIK: 0001431443 (see all company filings)

IRS No.: 261856183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A